SBIR Phase II: Mouthrinse Generator for Plaque and Halitosis Control

SBIR 第二阶段：用于控制牙菌斑和口臭的漱口水发生器

• 批准号: 0349689
• 负责人: Charles Tennakoon
• 金额: --
• 依托单位: Lynntech, Inc
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-03-01 至 2006-10-31
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=0349689&HistoricalAwards=false
• 关键词: SBIR; Phase; II; Mouthrinse; Generator

This Small Business Innovation Research (SBIR) Phase II will develop and commercialize electrochemically operated devices that will revolutionize the oral hygiene industry by providing an on-demand generation of mouthwash in a portable device and in an irrigator. The mouthwash generated in these devices will be effective in controlling halitosis and dental plaque and will also provide tooth whitening. In the Phase I study, all of the proposed objectives and specified criteria of success were accomplished to amply establish the proof of concept and feasibility of the project. In Phase II, further optimization of the parameters will be followed by the design and fabrication of prototypes in conjunction with a prominent company dealing with turnkey manufacturing, and the testing of 100 portable units in a clinical setting.The commercial impact of this project will be in the area of oral hygiene products. It is broadly estimated that up to 85 million Americans have halitosis, and over 35 million suffer from periodontal disease. Thus, the cost effective devices to be developed in this project are expected to have a large market potential in the $ 4.7 billion oral care industry.

这一小型企业创新研究(SBIR)第二阶段将开发和商业化电化学操作的设备，通过在便携式设备和冲洗器中提供按需生成的漱口水，从而彻底改变口腔卫生行业。这些设备产生的漱口水将有效地控制口臭和牙菌斑，并将提供牙齿美白。在第一阶段研究中，所有拟议的目标和具体的成功标准都已完成，以充分证明项目的概念和可行性。在第二阶段，将进一步优化参数，与一家从事交钥匙制造的知名公司合作设计和制造原型，并在临床环境中测试100台便携式设备。这项计划将在口腔卫生产品领域产生商业影响。据广泛估计，多达8500万美国人患有口臭，超过3500万人患有牙周病。因此，该项目将开发的高性价比设备有望在价值47亿美元的口腔护理行业具有巨大的市场潜力。